Eli Lilly stock (NYSE: LLY) fell over 6% on Wednesday, October 30, after it posted downbeat results. The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share ...
The Associated Press - Business News on MSN6d
Nasdaq edges back from its record as chip companies and Eli Lilly slumpU.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company ...
U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company ...
The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...
6don MSN
We recently compiled a list of the Jim Cramer’s Latest Game Plan: 20 Stocks to Watch. In this article, we are going to take a ...
Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...
By Lisa Pauline Mattackal (Reuters) -Futures tracking the tech-laden Nasdaq 100 rose on Wednesday, as strong quarterly ...
U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google's parent ...
Eli Lilly said it sees fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of $45.4 billion—$46.6 ...
AnaptysBio (ANAB) stock plunged after Eli Lilly's (LLY) decision to discontinue arthritis candidate peresolimab from its pipeline. Read more here.
Eli Lilly reported weaker results ... % for the worst loss since taking its place on the Nasdaq stock market following a merger with another company in March. The stock is notoriously volatile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback